Senta Jorinde Raasveld
Overview
Explore the profile of Senta Jorinde Raasveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flint A, Poole A, Raasveld S, Bailey M, Brady K, Chen P, et al.
Crit Care Explor
. 2025 Feb;
7(3):e1197.
PMID: 39982126
Importance: Blood transfusions are a common and potentially lifesaving intervention in ICU patients but are associated with harm and often transfused inconsistently with guidelines. However, it is not well known...
2.
van Haeren M, Raasveld S, de Bruin S, Reuland M, van den Oord C, Schenk J, et al.
Transfusion
. 2024 Dec;
65(1):73-87.
PMID: 39696779
Background: Current guidelines discourage prophylactic plasma use in non-bleeding patients. This study assesses global plasma transfusion practices in the intensive care unit (ICU) and their alignment with current guidelines. Study...
3.
Raasveld S, de Bruin S, Reuland M, van den Oord C, Schenk J, Aubron C, et al.
JAMA
. 2023 Oct;
330(19):1852-1861.
PMID: 37824112
Importance: Red blood cell (RBC) transfusion is common among patients admitted to the intensive care unit (ICU). Despite multiple randomized clinical trials of hemoglobin (Hb) thresholds for transfusion, little is...
4.
Raasveld S, Karami M, Schenk J, Dos Reis Miranda D, Mandigers L, Dauwe D, et al.
Transfusion
. 2023 Sep;
63(10):1809-1820.
PMID: 37668074
Background: Evidence-based recommendations for transfusion in patients with venoarterial extracorporeal membrane oxygenation (VA ECMO) are scarce. The current literature is limited to single-center studies with small sample sizes, therefore complicating...
5.
van Haeren M, Raasveld S, Karami M, Dos Reis Miranda D, Mandigers L, Dauwe D, et al.
Crit Care Explor
. 2023 Aug;
5(8):e0949.
PMID: 37614800
Objectives: To achieve optimal hemostatic balance in patients on extracorporeal membrane oxygenation (ECMO), a liberal transfusion practice is currently applied despite clear evidence. We aimed to give an overview of...
6.
Raasveld S, van den Oord C, Schenk J, van den Bergh W, Oude Lansink-Hartgring A, van der Velde F, et al.
Crit Care
. 2023 Aug;
27(1):321.
PMID: 37605277
Background: Thrombocytopenia, hemorrhage and platelet transfusion are common in patients supported with venoarterial extracorporeal membrane oxygenation (VA ECMO). However, current literature is limited to small single-center experiences with high degrees...
7.
Raasveld S, Volleman C, Combes A, Broman L, Taccone F, Peters E, et al.
Intensive Care Med Exp
. 2022 Nov;
10(1):50.
PMID: 36424482
Purpose: This scoping review aims to identify and describe knowledge gaps and research priorities in veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: An expert panel was recruited consisting of eight international...
8.
Raasveld S, Taccone F, Broman L, Hermans G, Meersseman P, Quintana Diaz M, et al.
Crit Care Explor
. 2022 Oct;
4(10):e0770.
PMID: 36248318
Objectives: To describe patient characteristics and outcomes in patients receiving VV ECMO due to COVID-19-induced ARDS and to assess the possible impact of COVID-19 on mortality. Design Setting And Participants:...
9.
Raasveld S, Karami M, van den Bergh W, Oude Lansink-Hartgring A, van der Velde F, Maas J, et al.
Crit Care Med
. 2022 Jan;
50(2):224-234.
PMID: 35100195
Objectives: In the general critical care patient population, restrictive transfusion regimen of RBCs has been shown to be safe and is yet implemented worldwide. However, in patients on venovenous extracorporeal...
10.
Dionne J, Oczkowski S, Hunt B, Antonelli M, Wijnberge M, Raasveld S, et al.
Crit Care Med
. 2021 Oct;
50(3):e313-e319.
PMID: 34709209
Objectives: Tranexamic acid is proposed as a treatment for gastrointestinal bleeding. The Haemorrhage Alleviation with Tranexamic Acid-Intestinal System trial evaluated extended-use (24 hr) high-dose tranexamic acid, prompting a reappraisal for...